Treatment of spinocerebellar ataxia with buspirone.

Abstract excerpt

Preliminary data suggest potential benefit of 5-HT receptor agonists in the treatment of ataxias. We studied the effects of buspirone in a cohort of twenty patients with spinocerebellar ataxia (SCA). Twenty patients were treated in this double-blind, placebo controlled, cross-over trial with eith...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Brain
• Share to Cross-Over Studies
• Share to Dose-Response Relationship, Drug